Thursday 11 July 2013, 2.00PM to 3.15pm
Speaker(s): Koonal Shah, Health Economist at Office of Health Economics
Abstract: In January 2009, the National Institute for Health and Care Excellence (NICE) issued supplementary advice to its Appraisal Committees to be taken into account when appraising life-extending ‘end of life’ treatments. This indicated that if certain criteria are met, it may be appropriate to recommend the use of end of life treatments that offer an extension to life even if their reference case incremental cost effectiveness ratios exceed the upper end of the range normally considered acceptable. However, the public consultation carried out by NICE revealed concerns that there is little evidence to support the premise that society is prepared to fund life-extending end of life treatments that would not meet the cost effectiveness criteria used for other treatments. In this seminar, I will present findings from an empirical study which elicited priority setting preferences of the general public concerning various end of life scenarios.
Location: ARRC Auditorium A/RC/014
Who to contact
For more information on these seminars, contact:
Adrian Villasenor
Adrian Villasenor-Lopez
Dacheng Huo
Dacheng Huo
If you are not a member of University of York staff and are interested in attending the seminar, please contact Adrian Villasenor-Lopez or Dacheng Huo so that we can ensure we have sufficient space
CHE Seminar Programme
- Thursday 12 January 2017
Jon Sussex, Chief Economist, RAND Europe- Thursday 9 February 2017
Richard Murray, Kings Fund